CollPlant GAAP net loss narrows to $2.73 million in Q2 2026; revenue falls 40% to $108,000 vs Q2 2025

Bitget2026/09/30 21:21

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

CollPlant posted a GAAP net loss of USD 2.7 million for the second quarter ended June 30, 2026; GAAP basic loss per share was USD 1.89.
GAAP revenue fell 40% to USD 108,000 from a year earlier; the decline was primarily attributed to lower rhCollagen-based product sales.
GAAP gross loss widened to USD 456,000 from USD 7,000, while GAAP operating expenses fell 31% to USD 2.2 million.
Cash and cash equivalents were USD 2.6 million at June 30, 2026; cash used in operating activities was USD 5.4 million for the six months.
September 2026 acquisition of LightSolver marked entry into photonic computing; CEO Yehiel Tal cited up to 80,000× acceleration in HLRS research.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Collplant Biotechnologies Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609301720PR_NEWS_USPR_____LN60606) on September 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

CollPlant GAAP net loss narrows to $2.73 million in Q2 2026; revenue falls 40% to $108,000 vs Q2 2025

You may also like

Crypto prices